image credit- freepik
KKR, a leading global investment firm, has announced the signing of definitive agreements under which funds managed by KKR will acquire Medicover India, the India hospital operations of leading international healthcare and diagnostic services provider Medicover AB.
Established in 2017, Medicover India is a multi-specialty hospital network with 24 hospitals and approximately 4,800 beds across South and West India. The company provides comprehensive care across more than 80 clinical specialties, supported by more than 1,900 doctors and advanced clinical infrastructure and technology, serving millions of patients each year.
KKR's investment reflects its belief in the long-term development of India's healthcare ecosystem. As India advances the objectives of the National Health Policy 2017, sustained investment in healthcare infrastructure, clinical capabilities, technology, and innovation will help strengthen the delivery of high-quality care for patients and communities across the country.
Trilegal is advising the minority shareholders of Medicover India on the sale of their stake in the company to funds managed by KKR. The transaction values Medicover India at EUR 1.2 billion.
Since 2004, KKR has invested more than $20 billion across the healthcare ecosystem globally, supporting healthcare providers and businesses in strengthening clinical capabilities, investing in technology and infrastructure, and expanding access to high-quality care. In India, KKR has invested across healthcare delivery, medical technology and related services, supporting businesses across the broader ecosystem.